Gland Pharma Schedules Board Meeting for Q2 FY27 Financial Results
Gland Pharma Ltd 路 Intimation 路 06 Nov 2026, 5:30 am
Gland Pharma Schedules Board Meeting for Q2 FY27 Financial Results Gland Pharma Limited will hold a Board of Directors meeting on 6th Nov'26 to consider and approve its unaudited standalone and consolidated financial results for the quarter and half year ended 30th Sep'26. The company will also host an earnings call for investors and analysts on 6th Nov'26 at 18:30 IST. Consequently, the insider trading window, closed since 1st Oct'26, is scheduled to reopen on 9th Nov'26.
Original exchange filing (PDF)
More announcements from Gland Pharma Ltd
- Schedule of Investor Meet Intimation 路 17 Nov 2026
- Allotment of 3739 Equity Shares on exercise of ESOPs 路 16 Nov 2026
- Grant of Options to Purchase Securities 路 16 Nov 2026
- Q2FY27 Earnings Call Transcript 路 12 Nov 2026
- Gland Pharma Limited has issued Corporate Guarantee on behalf of Phixen SAS, wholly owned step down subsidiary of the Company 路 12 Nov 2026
- Appointment of Mr. Xiao Le as Chief Investment Officer at Gland Pharma International Pte. Ltd, wholly owned subsidiary of Gland Pharma Limited, effective November 09, 2026 路 09 Nov 2026
- Q2FY27 Earnings Call Recording 路 07 Nov 2026
- Q2Fy27 Investors presentation 路 06 Nov 2026
